SARA ZINN: Open Payments
NPI 1801350426 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 12 payments from 7 companies in 2025. Trend: 2023 $66 · 2024 $263 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| ABBVIE INC. | 2 | $37 |
| Amgen Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Botanix SB Inc | 1 | $17 |
| Organon LLC | 2 | $11 |
Products named: TALTZ, COSENTYX, Otezla, RINVOQ, NEMLUVIO, SOFDRA, SKYRIZI, NEXPLANON.
Industry payments across FL — which companies pay providers there.
